Product Information
FAMOTIDINE 20 MG TABLET is a generic product labeled by McKesson, priced at $0.0303 per EA under NDC 63739064510. Its NADAC has been published 570 times since May 6, 2015.
FDA first approved this application on Apr 16, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
McKessonNDC
63739064510
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA075805FDA Approved
4/16/2001
TE Code
AB
On Market Since
4/16/2001
Pharmacological Classes
Price Statistics
The NADAC for FAMOTIDINE 20 MG TABLET has been published 570 times since May 6, 2015, and over the history we have for it it has declined 33.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0303 per EA |
|---|---|
| All-time high | $0.0599 (Jan 13, 2021) |
| All-time low | $0.0254 (Nov 20, 2024) |
| 52-week high | $0.0303 |
| 52-week low | $0.0289 |
| Median price | $0.0351 |
| Average price | $0.0367 |
| Largest weekly change | +27.4% (Nov 18, 2020) |
| Weeks tracked | 570 |
| Tracking since | May 6, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+3.1%
3Y
+0.4%
5Y
-26.3%
All
-33.2%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 24 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
McKesson manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FAMOTIDINE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FAMOTIDINE 20 MG TABLET, manufactured by McKesson, is $0.0303 per EA (NDC 63739064510), effective Apr 1, 2026.
How has the price of FAMOTIDINE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for FAMOTIDINE 20 MG TABLET has declined 33.2%. It has been tracked across 570 weekly CMS publications since May 6, 2015.
What are the highest and lowest recorded NADAC prices for FAMOTIDINE 20 MG TABLET?
Since May 6, 2015, the NADAC for FAMOTIDINE 20 MG TABLET has ranged from a low of $0.0254 (Nov 20, 2024) to a high of $0.0599 (Jan 13, 2021), with a median of $0.0351 per EA.
Are there cheaper alternatives to FAMOTIDINE 20 MG TABLET?
Yes. 24 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FAMOTIDINE 20 MG TABLET, is $0.0289 per EA — about 5% below FAMOTIDINE 20 MG TABLET.
Who manufactures FAMOTIDINE 20 MG TABLET?
FAMOTIDINE 20 MG TABLET (NDC 63739064510) is labeled by McKesson, and CMS classifies it as a generic product.